-
平臺(tái)編號：bio-131645
-
細(xì)胞信息： OC-1
-
規(guī)格：1×10?cells/T25培養(yǎng)瓶
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
人食管鱗癌細(xì)胞OC-1
細(xì)胞名稱：人食管鱗癌細(xì)胞OC-1
產(chǎn)品規(guī)格：T25培養(yǎng)瓶x1；1.5ml凍存管x2
細(xì)胞數(shù)量：1x10^6；1x10^6
保存溫度：37℃；-198℃
運(yùn)輸方式：常溫保溫運(yùn)輸；干冰運(yùn)輸
安全等級：1
用途限制：僅供科研2類
培養(yǎng)體系：DMEM高糖培養(yǎng)基+10%FBS+1%三抗
培養(yǎng)溫度：37℃
二氧化碳濃度：5%
簡介：人食管鱗癌細(xì)胞OC-1取自40歲男性供體腹水來源。
注釋：倍增時(shí)間38h
基因突變：/
HLA信息：/
STR信息：/
參考文獻(xiàn)
CLPUB00500
Collins J.K.,O'Mahony A.,O'Brien F.,Corbett A.,Morrissey D.,O'Donoghue M.,O'Sullivan G.
Evaluation of newly established cell lines as models to study growth,invasion and metastatic spread in oesophageal cancer.
Fibrinolysis 6 Suppl.4:83-88(1992)
PubMed=10390151;DOI=10.1023/A:1026470417680
Morrissey D.,O'Connell J.,Lynch D.,O'Sullivan G.C.,Shanahan F.,Collins J.K.
Invasion by esophageal cancer cells:functional contribution of the urokinase plasminogen activation system,and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.
Clin.Exp.Metastasis 17:77-85(1999)
PubMed=11297525;DOI=10.1074/jbc.M010847200
Barry O.P.,Mullan B.,Sheehan D.,Kazanietz M.G.,Shanahan F.,Collins J.K.,O'Sullivan G.C.
Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent.
J.Biol.Chem.276:15537-15546(2001)
PubMed=26512696;DOI=10.3390/cancers7040881
O'Callaghan C.,Fanning L.J.,Barry O.P.
Hypermethylation of MAPK13 promoter in oesophageal squamous cell carcinoma is associated with loss of p38delta MAPK expression.
Cancers(Basel)7:2124-2133(2015)
產(chǎn)品規(guī)格：T25培養(yǎng)瓶x1；1.5ml凍存管x2
細(xì)胞數(shù)量：1x10^6；1x10^6
保存溫度：37℃；-198℃
運(yùn)輸方式：常溫保溫運(yùn)輸；干冰運(yùn)輸
安全等級：1
用途限制：僅供科研2類
培養(yǎng)體系：DMEM高糖培養(yǎng)基+10%FBS+1%三抗
培養(yǎng)溫度：37℃
二氧化碳濃度：5%
簡介：人食管鱗癌細(xì)胞OC-1取自40歲男性供體腹水來源。
注釋：倍增時(shí)間38h
基因突變：/
HLA信息：/
STR信息：/
參考文獻(xiàn)
CLPUB00500
Collins J.K.,O'Mahony A.,O'Brien F.,Corbett A.,Morrissey D.,O'Donoghue M.,O'Sullivan G.
Evaluation of newly established cell lines as models to study growth,invasion and metastatic spread in oesophageal cancer.
Fibrinolysis 6 Suppl.4:83-88(1992)
PubMed=10390151;DOI=10.1023/A:1026470417680
Morrissey D.,O'Connell J.,Lynch D.,O'Sullivan G.C.,Shanahan F.,Collins J.K.
Invasion by esophageal cancer cells:functional contribution of the urokinase plasminogen activation system,and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.
Clin.Exp.Metastasis 17:77-85(1999)
PubMed=11297525;DOI=10.1074/jbc.M010847200
Barry O.P.,Mullan B.,Sheehan D.,Kazanietz M.G.,Shanahan F.,Collins J.K.,O'Sullivan G.C.
Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent.
J.Biol.Chem.276:15537-15546(2001)
PubMed=26512696;DOI=10.3390/cancers7040881
O'Callaghan C.,Fanning L.J.,Barry O.P.
Hypermethylation of MAPK13 promoter in oesophageal squamous cell carcinoma is associated with loss of p38delta MAPK expression.
Cancers(Basel)7:2124-2133(2015)
